Few Blockbusters So Far From China’s First-In-Class Innovation
Mixed Fortunes For Pioneers
Some five years on from the first approval of a novel drug originated in China, 10 first-in-class drugs of Chinese origin have been commercialized. But the results have been mixed, with few actual or potential blockbusters.
